1. Home
  2. ZNTL
  3. ZNTL News

Latest Zentalis Pharmaceuticals Inc. (ZNTL) News on November 12, 2025

Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress
ZNTL

GlobeNewswire

2 days ago

Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

9 days ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
ZNTL

GlobeNewswire

9 days ago

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
ZNTL

GlobeNewswire

a month ago

Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock
ZNTL

Simply Wall St.

a month ago

Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

a month ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Here's Why We're Watching Zentalis Pharmaceuticals' (NASDAQ:ZNTL) Cash Burn Situation
ZNTL

Simply Wall St.

5 months ago

Here's Why We're Watching Zentalis Pharmaceuticals' (NASDAQ:ZNTL) Cash Burn Situation

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

5 months ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals First Quarter 2025 Earnings: US$0.67 loss per share (vs US$0.14 profit in 1Q 2024)
ZNTL

Simply Wall St.

6 months ago

Zentalis Pharmaceuticals First Quarter 2025 Earnings: US$0.67 loss per share (vs US$0.14 profit in 1Q 2024)

Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress
ZNTL

GlobeNewswire

6 months ago

Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

6 months ago

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock
ZNTL

Simply Wall St.

6 months ago

Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock

ZNTL

MT Newswires

6 months ago

Zentalis Pharmaceuticals Doses 1st Patient in Part 2 of Ovarian Cancer Clinical Trial

Zentalis Pharmaceuticals Announces First Patient Dosed in DENALI Part 2 Clinical Trial of Azenosertib in Patients with Cyclin E1+ PROC
ZNTL

GlobeNewswire

6 months ago

Zentalis Pharmaceuticals Announces First Patient Dosed in DENALI Part 2 Clinical Trial of Azenosertib in Patients with Cyclin E1+ PROC

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting
ZNTL

GlobeNewswire

7 months ago

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

7 months ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates
ZNTL

GlobeNewswire

8 months ago

Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates

Zentalis Pharmaceuticals to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
ZNTL

GlobeNewswire

8 months ago

Zentalis Pharmaceuticals to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
ZNTL

GlobeNewswire

8 months ago

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

8 months ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
ZNTL

GlobeNewswire

8 months ago

Zentalis Pharmaceuticals Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
ZNTL

GlobeNewswire

9 months ago

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

Zentalis Pharmaceuticals (ZNTL): Among Cheapest Stocks Insiders Are Buying Recently
ZNTL

Insider Monkey

9 months ago

Zentalis Pharmaceuticals (ZNTL): Among Cheapest Stocks Insiders Are Buying Recently

ZNTL

Argus Research

9 months ago

Daily – Vickers Top Buyers & Sellers for 02/05/2025

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

9 months ago

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals (ZNTL) Loses -46.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ZNTL

Zacks

9 months ago

Zentalis Pharmaceuticals (ZNTL) Loses -46.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zentalis price target lowered to $10 from $20 at Oppenheimer
ZNTL

TipRanks

9 months ago

Zentalis price target lowered to $10 from $20 at Oppenheimer

Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer
ZNTL

GlobeNewswire

9 months ago

Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer

ZNTL

MT Newswires

9 months ago

Zentalis Pharmaceuticals to Cut 40% of Workforce

Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development
ZNTL

GlobeNewswire

9 months ago

Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development

US Exchange Penny Stocks To Watch In January 2025
ZNTL

Simply Wall St.

9 months ago

US Exchange Penny Stocks To Watch In January 2025

ZNTL

MT Newswires

10 months ago

Zentalis Pharma Says FDA Grants Fast Track Status on Azenosertib Cancer Drug Candidate

Zentalis Pharmaceuticals (ZNTL) Upgraded to Strong Buy: What Does It Mean for the Stock?
ZNTL

Zacks

10 months ago

Zentalis Pharmaceuticals (ZNTL) Upgraded to Strong Buy: What Does It Mean for the Stock?

Zentalis Pharmaceuticals Announces Azenosertib Fast Track Designation and Virtual Corporate Event to Present Updated Data from Azenosertib Clinical Studies
ZNTL

GlobeNewswire

10 months ago

Zentalis Pharmaceuticals Announces Azenosertib Fast Track Designation and Virtual Corporate Event to Present Updated Data from Azenosertib Clinical Studies

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

10 months ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 US Penny Stocks With Market Caps Under $300M
ZNTL

Simply Wall St.

a year ago

3 US Penny Stocks With Market Caps Under $300M

ZNTL

MT Newswires

a year ago

Lexeo Therapeutics Appoints Kyle Rasbach as CFO

Zentalis Pharmaceuticals Announces Key Management Appointments
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals Announces Key Management Appointments

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nano Dimension Leads 3 US Penny Stocks To Consider
ZNTL

Simply Wall St.

a year ago

Nano Dimension Leads 3 US Penny Stocks To Consider

ZNTL

MT Newswires

a year ago

Zentalis Pharmaceuticals Appoints Julie Eastland as CEO

Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Undervalued Opportunities: US Penny Stocks To Watch In October 2024
ZNTL

Simply Wall St.

a year ago

Undervalued Opportunities: US Penny Stocks To Watch In October 2024

State Street Corp's Strategic Reduction in Zentalis Pharmaceuticals Holdings
ZNTL

GuruFocus.com

a year ago

State Street Corp's Strategic Reduction in Zentalis Pharmaceuticals Holdings

Several Insiders Invested In Zentalis Pharmaceuticals Flagging Positive News
ZNTL

Simply Wall St.

a year ago

Several Insiders Invested In Zentalis Pharmaceuticals Flagging Positive News

FMR LLC Adjusts Its Stake in Zentalis Pharmaceuticals Inc
ZNTL

GuruFocus.com

a year ago

FMR LLC Adjusts Its Stake in Zentalis Pharmaceuticals Inc

Biotech Stock Roundup: GILD, NUVL Stocks Surge on Study Data, MRNA Down on Updates
ZNTL

Zacks

a year ago

Biotech Stock Roundup: GILD, NUVL Stocks Surge on Study Data, MRNA Down on Updates

FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor
ZNTL

Pharmaceutical Technology

a year ago

FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor

Zentalis Stock Up as FDA Lifts Partial Hold on Cancer Drug Studies
ZNTL

Zacks

a year ago

Zentalis Stock Up as FDA Lifts Partial Hold on Cancer Drug Studies

ZNTL

MT Newswires

a year ago

Top Midday Gainers

FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers
ZNTL

Benzinga

a year ago

FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers

Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies

Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis (ZNTL) Plunges More Than 70% in 3 Months: Here's Why
ZNTL

Zacks

a year ago

Zentalis (ZNTL) Plunges More Than 70% in 3 Months: Here's Why

ZNTL

MT Newswires

a year ago

Wedbush Upgrades Zentalis Pharmaceuticals to Neutral From Underperform on Valuation Post Sell-Off, PT is $4

ZNTL

MT Newswires

a year ago

Zentalis Pharmaceuticals Q2 Loss Narrows; Shares Fall

Zentalis Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Progress
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Progress

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
ZNTL

Zacks

a year ago

Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News

ZNTL

MT Newswires

a year ago

UBS Downgrades Zentalis Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $5 From $28

Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
ZNTL

Zacks

a year ago

Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold

FDA places partial clinical hold on Zentalis’ trials of azenosertib for cancer
ZNTL

Clinical Trials Arena

a year ago

FDA places partial clinical hold on Zentalis’ trials of azenosertib for cancer

ZNTL

MT Newswires

a year ago

US Equity Markets Close Up Tuesday Following Less-Than-Expected Retail Sales Growth

ZNTL

MT Newswires

a year ago

Top Midday Decliners

ZNTL

MT Newswires

a year ago

Stifel Adjusts Price Target on Zentalis Pharmaceuticals to $10 From $32, Maintains Buy Rating

ZNTL

MT Newswires

a year ago

Wells Fargo Downgrades Zentalis Pharmaceuticals to Equal Weight From Overweight, Lowers Price Target to $9 From $29

ZNTL

MT Newswires

a year ago

Zentalis Pharmaceuticals Shares Fall After FDA Places Partial Clinical Hold on Three Studies

Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program

We Think Zentalis Pharmaceuticals (NASDAQ:ZNTL) Can Afford To Drive Business Growth
ZNTL

Simply Wall St.

a year ago

We Think Zentalis Pharmaceuticals (NASDAQ:ZNTL) Can Afford To Drive Business Growth

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Insider Selling at Zentalis Pharmaceuticals Inc (ZNTL): President, Interim CFO Cam Gallagher ...
ZNTL

GuruFocus.com

a year ago

Insider Selling at Zentalis Pharmaceuticals Inc (ZNTL): President, Interim CFO Cam Gallagher ...

Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors

ZNTL

MT Newswires

a year ago

Zentalis Says Azenosertib Combo Shows 'Promise' in Relapsed Osteosarcoma Trial

Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meeting
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meeting

Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit
ZNTL

GlobeNewswire

a year ago

Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit

ZNTL

MT Newswires

2 years ago

Stifel Adjusts Price Target on Zentalis Pharmaceuticals to $32 From $36, Maintains Buy Rating

Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock
ZNTL

Simply Wall St.

2 years ago

Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock

ZNTL

GuruFocus.com

2 years ago

Zentalis Pharmaceuticals Reports Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic ...

Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
ZNTL

GlobeNewswire

2 years ago

Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

2 years ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024
ZNTL

GlobeNewswire

2 years ago

Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

2 years ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

2 years ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals, Inc.'s (NASDAQ:ZNTL) Intrinsic Value Is Potentially 98% Above Its Share Price
ZNTL

Simply Wall St.

2 years ago

Zentalis Pharmaceuticals, Inc.'s (NASDAQ:ZNTL) Intrinsic Value Is Potentially 98% Above Its Share Price

Wall Street Analysts Think Zentalis Pharmaceuticals, Inc. (ZNTL) Could Surge 136.44%: Read This Before Placing a Bet
ZNTL

Zacks

2 years ago

Wall Street Analysts Think Zentalis Pharmaceuticals, Inc. (ZNTL) Could Surge 136.44%: Read This Before Placing a Bet

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
ZNTL

GlobeNewswire

2 years ago

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

ZNTL

GuruFocus.com

2 years ago

Zentalis Pharmaceuticals Inc (ZNTL) Reports Full Year 2023 Financial Results and Provides ...

Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
ZNTL

GlobeNewswire

2 years ago

Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates

Down -19.06% in 4 Weeks, Here's Why You Should You Buy the Dip in Zentalis Pharmaceuticals, Inc. (ZNTL)
ZNTL

Zacks

2 years ago

Down -19.06% in 4 Weeks, Here's Why You Should You Buy the Dip in Zentalis Pharmaceuticals, Inc. (ZNTL)

Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences Conference
ZNTL

GlobeNewswire

2 years ago

Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences Conference

What Makes Zentalis Pharmaceuticals, Inc. (ZNTL) a New Buy Stock
ZNTL

Zacks

2 years ago

What Makes Zentalis Pharmaceuticals, Inc. (ZNTL) a New Buy Stock

Insider Sell: President Cam Gallagher Sells 11,552 Shares of Zentalis Pharmaceuticals Inc (ZNTL)
ZNTL

GuruFocus.com

2 years ago

Insider Sell: President Cam Gallagher Sells 11,552 Shares of Zentalis Pharmaceuticals Inc (ZNTL)

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZNTL

GlobeNewswire

2 years ago

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ZNTL

Thomson Reuters StreetEvents

2 years ago

Q4 2023 First Merchants Corp Earnings Call

Goldman Sachs Group Inc's Chief Accounting Officer Sells Company Shares
ZNTL

GuruFocus.com

2 years ago

Goldman Sachs Group Inc's Chief Accounting Officer Sells Company Shares

First Merchants (FRME) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
ZNTL

Zacks

2 years ago

First Merchants (FRME) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Share on Social Networks: